[1] MAEDER M T,SCHOCH O D,RICHLI H.A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease[J].Vasc Health Risk Manag,2016,12:85-103.
[2] DRAGER L F,MCEVOY R D,BARBE F,et al.Sleep apnea and cardiovascular disease:lessons from recent trials and need for team science[J].Circulation,2017,136(19):1840-1850.
[3] SELIM S,SUNKARA M,SALOUS A K,et al.Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit,but variably restored by red blood cell transfusions[J].Clin Sci (Lond),2011,121(12):565-572.
[4] SUGIURA T,DOHI Y,YAMASHITA S,et al.Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis[J].Coron Artery Dis,2012,23(4):234-238.
[5] GOZAL D.Pediatric OSA:a case for "united we stand" in the way of a breath[J].Pediatr Pulmonol,2010,45(12):1151-1152.
[6] 中华医学会呼吸病学分会睡眠呼吸疾病学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)[J].中华结核和呼吸杂志,2011,35(1):594-597.
[7] INONU K H,PAZARLI A C,KANBAY A,et al.Monocyte count/HDL cholesterol ratio and cardiovascular disease in patients with obstructive sleep apnea syndrome:a multicenter study[J].Clin Appl Thromb Hemost,2018,24(1):139-144.
[8] 吴悦陶,刘瑞洪.阻塞型睡眠呼吸暂停综合征与动脉粥样硬化[J].临床与病理杂志,2007,27(4):324-327.
[9] BERGER S,LAVIE L.Endothelial progenitor cells in cardiovascular disease and hypoxia——potential implications to obstructive sleep apnea[J].Transl Res,2011,158(1):1-13.
[10] CARPAGNANO G E,SPANEVWLLO A,SABATO R,et al.Systemic and airway inflammation in sleep apnea and obesity:the role of ICAM-1 and IL-8[J].Transl Res,2010,155(1):35-43.
[11] MANDAL S,KENT B D.Obstructive sleep apnoea and coronary artery disease[J].J Thorac Dis,2018,10(S34):S4212-S4220.
[12] COELHO F M,PRADELLA-HALLINAN M,PALOMBINI L,et a1.The STOP-BANG questionnaire was a useful tool to identify OSA during epidemiological study in Sao Paulo(Brazil)[J].Sleep Med,2012,13(4):450-451.
[13] LEVY P,TAMISIER R,ARNAUD C,et al.Sleep deprivation,sleep apnea and cardiovascular diseases[J].Front Biosci,2012,4(6):2007-2021.
[14] HAO W,WANG X,FAN J,et al.Association between apnea-hypopnea index and coronary artery calcification:a systematic review and meta-analysis[J].Ann Med,2021,53(1):302-317.
[15] SATTLER K J,ELBASAN S,KEUL P,et al.Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease[J].Basic Res Cardiol,2010,105(6):821-832.
[16] ARGRAVES K M,GAZZOLO P J,GROH E M,et al.High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function[J].J Biol Chem,2008,283(36):25074-25081.
[17] DEUTSCHMAN D H,CARSTENS J S,KLEPPER R L,et al.Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate[J].Am Heart J,2003,146(1):62-68.
[18] 贺苗,赵杰,苏健,等.1-磷酸鞘氨醇后适应对大鼠心肌缺血/再灌注损伤的保护作用[J].中国药理学通报,2013,29(10):1369-1373. |